Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125286161 | 12528616 | 1 | I | 20160701 | 20160705 | 20160705 | EXP | SV-GLAXOSMITHKLINE-SV2016GSK095459 | GLAXOSMITHKLINE | 80.00 | YR | F | Y | 0.00000 | 20160705 | CN | SV | SV |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125286161 | 12528616 | 1 | PS | Relvar Ellipta | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | UNK, RELVAR 100/25 | Y | 204275 | ||||||||||
| 125286161 | 12528616 | 2 | SS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK, SERETIDE 50/500 | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125286161 | 12528616 | 1 | Asthma |
| 125286161 | 12528616 | 2 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125286161 | 12528616 | HO |
| 125286161 | 12528616 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125286161 | 12528616 | Asthma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |